Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 3 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 7 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HQ99
Term | Name | Level | Count |
---|---|---|---|
GO:0006950 | response to stress | 2 | 8 |
GO:0006979 | response to oxidative stress | 3 | 8 |
GO:0009987 | cellular process | 1 | 8 |
GO:0033554 | cellular response to stress | 3 | 8 |
GO:0034599 | cellular response to oxidative stress | 4 | 8 |
GO:0042221 | response to chemical | 2 | 8 |
GO:0050896 | response to stimulus | 1 | 8 |
GO:0051716 | cellular response to stimulus | 2 | 8 |
GO:0062197 | cellular response to chemical stress | 4 | 8 |
GO:0070887 | cellular response to chemical stimulus | 3 | 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 8 |
GO:0016491 | oxidoreductase activity | 2 | 8 |
GO:0016651 | oxidoreductase activity, acting on NAD(P)H | 3 | 8 |
GO:0016657 | oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor | 4 | 8 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 42 | 44 | PF00675 | 0.305 |
CLV_PCSK_KEX2_1 | 41 | 43 | PF00082 | 0.296 |
CLV_PCSK_PC1ET2_1 | 41 | 43 | PF00082 | 0.413 |
CLV_PCSK_SKI1_1 | 190 | 194 | PF00082 | 0.329 |
CLV_PCSK_SKI1_1 | 97 | 101 | PF00082 | 0.331 |
DOC_MAPK_gen_1 | 77 | 85 | PF00069 | 0.189 |
DOC_PP4_FxxP_1 | 193 | 196 | PF00568 | 0.329 |
DOC_USP7_MATH_1 | 206 | 210 | PF00917 | 0.329 |
DOC_USP7_MATH_1 | 216 | 220 | PF00917 | 0.601 |
DOC_USP7_MATH_1 | 23 | 27 | PF00917 | 0.623 |
DOC_USP7_UBL2_3 | 57 | 61 | PF12436 | 0.230 |
DOC_USP7_UBL2_3 | 97 | 101 | PF12436 | 0.270 |
LIG_14-3-3_CanoR_1 | 145 | 151 | PF00244 | 0.189 |
LIG_14-3-3_CanoR_1 | 43 | 49 | PF00244 | 0.307 |
LIG_14-3-3_CterR_2 | 229 | 233 | PF00244 | 0.414 |
LIG_Actin_WH2_2 | 88 | 103 | PF00022 | 0.270 |
LIG_BIR_III_2 | 215 | 219 | PF00653 | 0.460 |
LIG_FHA_2 | 102 | 108 | PF00498 | 0.329 |
LIG_FHA_2 | 189 | 195 | PF00498 | 0.189 |
LIG_FHA_2 | 60 | 66 | PF00498 | 0.293 |
LIG_LIR_Apic_2 | 191 | 196 | PF02991 | 0.202 |
LIG_LIR_Gen_1 | 197 | 207 | PF02991 | 0.346 |
LIG_LIR_Nem_3 | 142 | 146 | PF02991 | 0.184 |
LIG_LIR_Nem_3 | 197 | 202 | PF02991 | 0.329 |
LIG_SH2_SRC | 130 | 133 | PF00017 | 0.440 |
LIG_SH2_SRC | 35 | 38 | PF00017 | 0.436 |
LIG_SH2_STAP1 | 130 | 134 | PF00017 | 0.250 |
LIG_SH2_STAP1 | 146 | 150 | PF00017 | 0.430 |
LIG_SH2_STAT5 | 109 | 112 | PF00017 | 0.237 |
LIG_SH2_STAT5 | 35 | 38 | PF00017 | 0.436 |
LIG_SH3_3 | 215 | 221 | PF00018 | 0.456 |
LIG_SH3_3 | 25 | 31 | PF00018 | 0.464 |
LIG_SH3_4 | 30 | 37 | PF00018 | 0.425 |
LIG_TRAF2_1 | 104 | 107 | PF00917 | 0.329 |
LIG_WRC_WIRS_1 | 150 | 155 | PF05994 | 0.346 |
MOD_CK1_1 | 149 | 155 | PF00069 | 0.278 |
MOD_CK1_1 | 44 | 50 | PF00069 | 0.189 |
MOD_CK1_1 | 5 | 11 | PF00069 | 0.599 |
MOD_CK2_1 | 101 | 107 | PF00069 | 0.279 |
MOD_CK2_1 | 52 | 58 | PF00069 | 0.329 |
MOD_GlcNHglycan | 131 | 135 | PF01048 | 0.302 |
MOD_GlcNHglycan | 157 | 160 | PF01048 | 0.272 |
MOD_GlcNHglycan | 166 | 169 | PF01048 | 0.274 |
MOD_GlcNHglycan | 23 | 26 | PF01048 | 0.663 |
MOD_GlcNHglycan | 31 | 34 | PF01048 | 0.687 |
MOD_GSK3_1 | 151 | 158 | PF00069 | 0.286 |
MOD_GSK3_1 | 37 | 44 | PF00069 | 0.329 |
MOD_GSK3_1 | 48 | 55 | PF00069 | 0.329 |
MOD_GSK3_1 | 59 | 66 | PF00069 | 0.366 |
MOD_LATS_1 | 89 | 95 | PF00433 | 0.189 |
MOD_N-GLC_2 | 117 | 119 | PF02516 | 0.243 |
MOD_NEK2_1 | 151 | 156 | PF00069 | 0.302 |
MOD_NEK2_1 | 4 | 9 | PF00069 | 0.524 |
MOD_NEK2_1 | 48 | 53 | PF00069 | 0.352 |
MOD_NEK2_2 | 206 | 211 | PF00069 | 0.375 |
MOD_PIKK_1 | 151 | 157 | PF00454 | 0.346 |
MOD_PK_1 | 41 | 47 | PF00069 | 0.254 |
MOD_PKA_1 | 101 | 107 | PF00069 | 0.347 |
MOD_PKA_1 | 41 | 47 | PF00069 | 0.329 |
MOD_PKA_2 | 41 | 47 | PF00069 | 0.288 |
MOD_Plk_1 | 48 | 54 | PF00069 | 0.189 |
MOD_Plk_1 | 63 | 69 | PF00069 | 0.153 |
MOD_Plk_2-3 | 107 | 113 | PF00069 | 0.189 |
MOD_Plk_4 | 123 | 129 | PF00069 | 0.270 |
MOD_Plk_4 | 146 | 152 | PF00069 | 0.324 |
MOD_SUMO_rev_2 | 107 | 116 | PF00179 | 0.329 |
MOD_SUMO_rev_2 | 209 | 219 | PF00179 | 0.564 |
TRG_DiLeu_BaEn_1 | 197 | 202 | PF01217 | 0.329 |
TRG_ENDOCYTIC_2 | 181 | 184 | PF00928 | 0.270 |
TRG_NES_CRM1_1 | 183 | 198 | PF08389 | 0.329 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IAF5 | Leptomonas seymouri | 65% | 100% |
A0A3Q8IWH0 | Leishmania donovani | 74% | 100% |
C9ZSG5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 46% | 100% |
E9AHY5 | Leishmania infantum | 74% | 100% |
E9AU17 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 76% | 100% |
P37261 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 30% | 100% |
Q4Q0H8 | Leishmania major | 74% | 100% |
Q96VH4 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 33% | 100% |